Black clouds and black boxes

Archives of Internal Medicine

Volumn 172, Issue 18, 2012, Pages 1375-1376

  Chan, Chee M ^a   Shorr, Andrew F ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID;

ARTICLE; ASTHMA; DISEASE CONTROL; DRUG SAFETY; FOLLOW UP; HEALTH CARE POLICY; HUMAN; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT;

ADRENAL CORTEX HORMONES; ADRENERGIC BETA-2 RECEPTOR AGONISTS; ANTI-ASTHMATIC AGENTS; ASTHMA; HUMANS;

EID: 84867365196     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2012.3650     Document Type: Article

References (7)

1. Castle W, Fuller R, Hall J, Palmer J. Serevent Nationwide Surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment. BMJ. 1993;306(6884):1034-1037. (Pubitemid 23105961)
2. Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM; SMART Study Group. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest. 2006;129(1):15-26. (Pubitemid 43265239)
3. National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of asthma - summary report 2007. J Allergy Clin Immunol . 2007;120(5)(suppl):S94-S138.
4. Chowdhury BA, Seymour SM, Levenson MS. Assessing the safety of adding LABAs to inhaled corticosteroids for treating asthma. N Engl J Med. 2011;364(26):2473-2475.
5. Levenson M. Long-acting beta-agonists and adverse asthma events meta-analysis. http: //www.fda.gov/ohrms/dockets/ac/08/briefing/2008-4398b1-01- FDA.pdf. Published November 12, 2008. Accessed June 1, 2012.
6. Akinbami LJ, Moorman JE, Bailey C, et al. Trends in asthma prevalence, health care use, andmortality in the United States, 2001-2010. NCHSData Brief. 2012;24(94):1-8.
7. Brozek JL, Kraft M, Krishnan JA, et al. Long-acting β2-agonist step-off in patients with controlled asthma: systematic review with meta-analysis [published onlineAugust 27, 2012]. Arch Intern Med. 2012;172(18):1365-1375.